These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Atrial fibrillation: molecular biology has yet to impact management. El-Sherif N; Baroudi G J Cardiovasc Electrophysiol; 2004 Feb; 15(2):224-5. PubMed ID: 15028054 [No Abstract] [Full Text] [Related]
43. Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period. Wozakowska-Kapłon B Int J Cardiol; 2005 May; 101(1):47-52. PubMed ID: 15860382 [TBL] [Abstract][Full Text] [Related]
44. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Sparks PB; Morton JB; Kalman JM J Cardiovasc Electrophysiol; 2012 Mar; 23(3):232-8. PubMed ID: 21955090 [TBL] [Abstract][Full Text] [Related]
45. Diverse Fibrosis Architecture and Premature Stimulation Facilitate Initiation of Reentrant Activity Following Chronic Atrial Fibrillation. Angel N; Li LI; Macleod RS; Marrouche N; Ranjan R; Dosdall DJ J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1352-60. PubMed ID: 26249367 [TBL] [Abstract][Full Text] [Related]
46. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528 [TBL] [Abstract][Full Text] [Related]
47. Atrial fibrillation in horses part 1: Pathophysiology. Decloedt A; Van Steenkiste G; Vera L; Buhl R; van Loon G Vet J; 2020 Sep; 263():105521. PubMed ID: 32928494 [TBL] [Abstract][Full Text] [Related]
48. Characteristics of atrial fibrillation and comorbidities in familial atrial fibrillation. Jurkko R; Palojoki E; Huttunen H; Holm C; Lehto M; Heliö T; Swan H; Toivonen L J Cardiovasc Electrophysiol; 2013 Jul; 24(7):768-74. PubMed ID: 23551519 [TBL] [Abstract][Full Text] [Related]
49. Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant. Soucek R; Thomas D; Kelemen K; Bikou O; Seyler C; Voss F; Becker R; Koenen M; Katus HA; Bauer A Heart Rhythm; 2012 Feb; 9(2):265-72. PubMed ID: 21907172 [TBL] [Abstract][Full Text] [Related]
50. Atrial structural remodeling in patients with atrial chronic fibrillations and in animal models. Laky D; Parascan L; Cândea V Rom J Morphol Embryol; 2011; 52(1):95-8. PubMed ID: 21424038 [TBL] [Abstract][Full Text] [Related]
51. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. Benito B; Brugada R; Perich RM; Lizotte E; Cinca J; Mont L; Berruezo A; Tolosana JM; Freixa X; Brugada P; Brugada J Heart Rhythm; 2008 Oct; 5(10):1434-40. PubMed ID: 18929331 [TBL] [Abstract][Full Text] [Related]
52. Three-dimensional Integrated Functional, Structural, and Computational Mapping to Define the Structural "Fingerprints" of Heart-Specific Atrial Fibrillation Drivers in Human Heart Ex Vivo. Zhao J; Hansen BJ; Wang Y; Csepe TA; Sul LV; Tang A; Yuan Y; Li N; Bratasz A; Powell KA; Kilic A; Mohler PJ; Janssen PML; Weiss R; Simonetti OP; Hummel JD; Fedorov VV J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862969 [TBL] [Abstract][Full Text] [Related]
53. Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis. Lau DH; Linz D; Schotten U; Mahajan R; Sanders P; Kalman JM Heart Lung Circ; 2017 Sep; 26(9):887-893. PubMed ID: 28610723 [TBL] [Abstract][Full Text] [Related]
54. TBX5 loss-of-function mutation contributes to atrial fibrillation and atypical Holt-Oram syndrome. Guo DF; Li RG; Yuan F; Shi HY; Hou XM; Qu XK; Xu YJ; Zhang M; Liu X; Jiang JQ; Yang YQ; Qiu XB Mol Med Rep; 2016 May; 13(5):4349-56. PubMed ID: 27035640 [TBL] [Abstract][Full Text] [Related]
55. Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate. Goldberger JJ; Arora R; Green D; Greenland P; Lee DC; Lloyd-Jones DM; Markl M; Ng J; Shah SJ Circulation; 2015 Jul; 132(4):278-91. PubMed ID: 26216085 [TBL] [Abstract][Full Text] [Related]
56. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation. Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222 [TBL] [Abstract][Full Text] [Related]
58. Intra-Atrial Conduction Delay Revealed by Multisite Incremental Atrial Pacing is an Independent Marker of Remodeling in Human Atrial Fibrillation. Williams SE; Linton NWF; Harrison J; Chubb H; Whitaker J; Gill J; Rinaldi CA; Razavi R; Niederer S; Wright M; O'Neill M JACC Clin Electrophysiol; 2017 Sep; 3(9):1006-1017. PubMed ID: 28966986 [TBL] [Abstract][Full Text] [Related]
59. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Lin PH; Lee SH; Su CP; Wei YH Free Radic Biol Med; 2003 Nov; 35(10):1310-8. PubMed ID: 14607530 [TBL] [Abstract][Full Text] [Related]
60. Aging Modulates the Substrate and Triggers Remodeling in Atrial Fibrillation. Lin YK; Chen YA; Lee TI; Chen YC; Chen SA; Chen YJ Circ J; 2018 Apr; 82(5):1237-1244. PubMed ID: 28904308 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]